BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma
Clinical trial NCT06745687 · RECRUITING
Trial details
- NCT number
- NCT06745687
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2027-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.